Spots Global Cancer Trial Database for gemcitabine hydrochloride
Every month we try and update this database with for gemcitabine hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00090909 | Lymphoma | cisplatin dexamethasone gemcitabine hyd... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | NCT01983969 | Advanced Cancer... Lymphoma | Azacitidine Vorinostat Gemcitabine Busulfan Melphalan Dexamethasone Caphosol Glutamine Pyridoxine Rituximab | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer | NCT03816358 | Pancreatic Aden... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | Anetumab Ravtan... Biopsy Biospecimen Col... Gemcitabine Hyd... Ipilimumab Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | NCT00084942 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | Roswell Park Cancer Institute | |
| Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | NCT00357630 | Carcinoma of Un... Pain | gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT00004003 | Pancreatic Canc... | cisplatin fluorouracil gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01473940 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | ipilimumab gemcitabine hyd... laboratory biom... | 18 Years - | Northwestern University | |
| Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | NCT02178436 | Acinar Cell Ade... Duct Cell Adeno... Stage IV Pancre... | gemcitabine hyd... Selinexor Pharmacological... Laboratory Biom... Nab paclitaxel | 19 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00262860 | Lymphoma | bortezomib gemcitabine hyd... | 18 Years - 120 Years | University of Rochester | |
| Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer | NCT02996825 | Recurrent Breas... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Triple-Negative... | Gemcitabine Gemcitabine Hyd... Laboratory Biom... Mirvetuximab So... Pharmacological... | - | City of Hope Medical Center | |
| ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | NCT01154426 | Adult Solid Neo... BRCA1 Mutation ... BRCA2 Mutation ... | Diagnostic Labo... Gemcitabine Hyd... Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00003037 | Lung Cancer | cisplatin docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | NCT00006459 | Breast Cancer | gemcitabine hyd... paclitaxel | 18 Years - | Eli Lilly and Company | |
| Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | NCT00268411 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | NCT02048943 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01098344 | Pancreatic Canc... | Notch signaling... gemcitabine hyd... imaging biomark... laboratory biom... pharmacological... | 18 Years - | Cancer Research UK | |
| Gemox as First and Second Line Therapy in Unknown Primary Cancer | NCT00353145 | Unknown Primary... | Gemcitabine (Ge... Oxaliplatin Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00820898 | Endometrial Ade... Endometrial Ade... Endometrial Cle... Recurrent Uteri... | Gemcitabine Hyd... | 18 Years - | GOG Foundation | |
| Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | NCT00005870 | Pancreatic Canc... | fluorouracil gemcitabine hyd... mitomycin C rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma | NCT00863369 | Lymphoma | rituximab bortezomib gemcitabine hyd... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer | NCT02227940 | Advanced Malign... ALK Positive Metastatic Panc... Stage III Pancr... Stage IV Pancre... | Ceritinib Cisplatin Gemcitabine Hyd... Laboratory Biom... Paclitaxel Albu... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment | NCT00881387 | Lymphoma | rituximab gemcitabine hyd... vinorelbine dit... | 18 Years - 120 Years | University of Miami | |
| Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00182806 | Lung Cancer | gemcitabine hyd... irinotecan hydr... | 18 Years - | Roswell Park Cancer Institute | |
| Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02446600 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... | Biospecimen Col... Carboplatin Cediranib Malea... Computed Tomogr... Echocardiograph... Gemcitabine Gemcitabine Hyd... Laboratory Biom... Magnetic Resona... Multigated Acqu... Olaparib Paclitaxel Pegylated Lipos... Pharmacological... Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | NCT00003342 | Bladder Cancer Transitional Ce... | filgrastim carboplatin doxorubicin hyd... gemcitabine hyd... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | NCT00305877 | Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... | cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer | NCT02437370 | Metastatic Urot... Recurrent Bladd... Recurrent Uroth... Regional Urothe... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Stage IV Urethr... Urethral Urothe... | Pembrolizumab Docetaxel Gemcitabine Hyd... | 18 Years - | University of California, Davis | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | NCT00006462 | Leukemia | gemcitabine hyd... | - 21 Years | Children's Oncology Group | |
| Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | NCT00072436 | Unspecified Adu... | gemcitabine hyd... alvocidib pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | NCT00003723 | Malignant Mesot... | gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | NCT00007917 | Unspecified Adu... | alvocidib gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | NCT00114244 | Stage IV Pancre... | sorafenib tosyl... gemcitabine hyd... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00016367 | Lung Cancer | Trastuzumab Cisplatin Gemcitabine Hyd... | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer | NCT00627432 | Bladder Cancer | gemcitabine hyd... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | NCT00005870 | Pancreatic Canc... | fluorouracil gemcitabine hyd... mitomycin C rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma | NCT00086801 | Lymphoma | doxorubicin hyd... gemcitabine hyd... vinblastine fludeoxyglucose... CT scan | 16 Years - | Alliance for Clinical Trials in Oncology | |
| S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer | NCT00445601 | Bladder Cancer | gemcitabine hyd... placebo | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer | NCT00577889 | Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre... | gemcitabine hyd... tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer | NCT00006007 | Breast Cancer | gemcitabine hyd... pemetrexed diso... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer | NCT00093496 | Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | gemcitabine hyd... tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer | NCT01195415 | Recurrent Pancr... Stage IV Pancre... | Gemcitabine Hyd... Laboratory Biom... Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00047047 | Unspecified Adu... | gemcitabine hyd... tanespimycin cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) | NCT04871529 | Bladder Carcino... Infiltrating Re... Stage II Bladde... | Therapeutic Con... Avelumab Gemcitabine Hyd... Carboplatin | 18 Years - | SWOG Cancer Research Network | |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | NCT00004861 | Pancreatic Canc... | gemcitabine hyd... tacedinaline | 18 Years - | Pfizer | |
| Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003202 | Lung Cancer | cisplatin gemcitabine hyd... radiation thera... | - 120 Years | Wake Forest University Health Sciences | |
| Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | NCT01017822 | Pancreatic Canc... | conatumumab capecitabine gemcitabine hyd... 3-dimensional c... | 18 Years - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00003001 | Colorectal Canc... | fluorouracil gemcitabine hyd... leucovorin calc... | - | National Cancer Institute (NCI) | |
| First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00736814 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00009893 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | fluorouracil gemcitabine hyd... leucovorin calc... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus | NCT00003316 | Sarcoma | gemcitabine hyd... | 18 Years - | GOG Foundation | |
| 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer | NCT00095888 | Male Breast Can... Recurrent Breas... Stage IV Breast... | triapine gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer | NCT04491942 | Advanced Bile D... Advanced Breast... Advanced Cervic... Advanced Endome... Advanced Esopha... Advanced Gastri... Advanced Head a... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Ovaria... Advanced Penile... Advanced Pleura... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Stage III Cervi... Stage III Dista... Stage III Intra... Stage III Lung ... Stage III Ovari... Stage III Penil... Stage III Pleur... Stage IV Cervic... Stage IV Distal... Stage IV Intrah... Stage IV Lung C... Stage IV Ovaria... Stage IV Penile... Stage IV Pleura... Triple-Negative... Unresectable Ur... | Cisplatin Elimusertib Gemcitabine Hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer | NCT00016315 | Lung Cancer | carboplatin gemcitabine hyd... paclitaxel radiation thera... | - | Radiation Therapy Oncology Group | |
| First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00736814 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003930 | Bladder Cancer | cisplatin gemcitabine hyd... paclitaxel conventional su... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00074204 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... | 18 Years - | Case Comprehensive Cancer Center | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | NCT00003780 | Pancreatic Canc... | tumor infiltrat... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | NCT01100372 | Fallopian Tube ... Ovarian Cancer Primary Periton... | gemcitabine hyd... liposome-encaps... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | NCT00064064 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | NCT00789958 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | NCT00005869 | Pancreatic Canc... | gemcitabine hyd... rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | NCT01234935 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem... | 18 Years - | Translational Oncology Research International | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00005972 | Lung Cancer | gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane | NCT00059852 | Breast Cancer | erlotinib hydro... gemcitabine hyd... | 18 Years - | Alliance for Clinical Trials in Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
